Sökning: "Hälsoekonomi"
Visar resultat 1 - 5 av 216 avhandlingar innehållade ordet Hälsoekonomi.
1. Health economic aspects of diabetic retinopathy
Sammanfattning : To ensure that the resources of the health care sector are used effectively, new technologies need to be evaluated before implementation to examine if they generate health outcomes at an acceptable cost. This information can be collected by performing health economic evaluations in which the costs and health outcomes of different technologies are compared. LÄS MER
2. Cost-effectiveness and Value of Further Research of Treatment Strategies for Cardiovascular Disease
Sammanfattning : Economic evaluations provide a tool to estimate costs and health consequences of competing medical technologies, ultimately to aid decision makers when deciding which medical technologies should be funded from available resources. Such decisions inevitably need to be taken under uncertainty and it is not clear how to approach them in health care decision-making. LÄS MER
3. Designing for Legitimacy : Policy Work and the Art of Juggling When Setting Limits in Health Care
Sammanfattning : Limit-setting in publicly funded healthcare is unavoidable, and increasingly important in the governance and management of the demand for health services. The work of limit-setting takes place in the organising of the provision of health services, where various health workers (professionals, administrators, unit managers, politicians) collectively exercise their skills. LÄS MER
4. Disability, rehabilitation and health economic assessment
Sammanfattning : Background: Disability caused by long-term illnesses and diseases involves welfare losses through human suffering and huge societal costs. Rehabilitation of disabled individuals is a complex and growing field where health economic assessment studies could play a role in health policy and medical decision-making. LÄS MER
5. Towards a Health Economic Simulation Model of Type 2 Diabetes in Sweden
Sammanfattning : The aim of this thesis was to provide part of the data required in updating/developing computer simulation models (CSMs) for type 2 diabetes mellitus (T2DM) using data obtained from routine clinical practice in Sweden. In paper I, evolution of five biomarkers (i.e. LÄS MER